Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Alcazar

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|March 29, 2024
Pathologic features of brain hemorrhage after radiation treatment: case series with somatic mutation analysisRoberto J Alcazar-Felix, Abhinav Srinath, Stephanie Hage, et al.
Neuroimage|May 14, 2013
Preclinical evaluation of [(18)F]JNJ42259152 as a PET tracer for PDE10AS Celen, M Koole, M Ooms, et al.
The Journal of Biological Chemistry|April 10, 2021
SNAP23 is essential for platelet and mast cell development and required in connective tissue mast cells for anaphylaxisRodolfo A Cardenas, Ricardo Gonzalez, Elizabeth Sanchez, et al.
Cerebrovascular Diseases (Basel, Switzerland)|April 24, 2026
Functional and Patient-reported Outcomes in the Atorvastatin versus Placebo Trial of Hemorrhagic Cerebral Cavernous Malformations: An Exploratory StudyGeorgeio Sader, Roberto J Alcazar-Felix, Aditya Jhaveri, et al.
Frontiers in Physiology|January 28, 2026
Exploring the physiological limits of aging: a case study of the male 50-km world record in the 80+ age categoryA M Pilotto, E Higueras-Liébana, M Ansaldo, et al.
Journal of the American Heart Association|January 29, 2026
Recurrent Symptomatic Hemorrhage in Cerebral Cavernous Malformations After Discontinuation of Atorvastatin or PlaceboBader Ali, Robert Shenkar, Justine Lee, et al.
Acta Neuropathologica Communications|September 24, 2025
A mouse model of stereotactic radiosurgery-induced neuroinflammation and blood-brain barrier compromiseRoberto J Alcazar-Felix, Lin Cheng, Abhinav Srinath, et al.
Neurosurgery|October 21, 2025
Relevance of Lesion Volume as an Outcome in Cerebral Cavernous Malformation Drug Trial: Exploratory Analyses in Atorvastatin Treatment of Cavernous Angiomas with Symptomatic Hemorrhage Exploratory Proof of ConceptRoberto J Alcazar-Felix, Richard E Thompson, Agnieszka Stadnik, et al.
International Journal of Molecular Sciences|May 7, 2025
A Systematic Review of MicroRNAs in Hemorrhagic Neurovascular Disease: Cerebral Cavernous Malformations as a ParadigmRoberto J Alcazar-Felix, Aditya Jhaveri, Javed Iqbal, et al.
Translational Stroke Research|July 9, 2024
Except for Robust Outliers, Rapamycin Increases Lesion Burden in a Murine Model of Cerebral Cavernous MalformationsRoberto J Alcazar-Felix, Robert Shenkar, Christian R Benavides, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|March 29, 2024
Pathologic features of brain hemorrhage after radiation treatment: case series with somatic mutation analysisRoberto J Alcazar-Felix, Abhinav Srinath, Stephanie Hage, et al.
Neuroimage|May 14, 2013
Preclinical evaluation of [(18)F]JNJ42259152 as a PET tracer for PDE10AS Celen, M Koole, M Ooms, et al.
The Journal of Biological Chemistry|April 10, 2021
SNAP23 is essential for platelet and mast cell development and required in connective tissue mast cells for anaphylaxisRodolfo A Cardenas, Ricardo Gonzalez, Elizabeth Sanchez, et al.
Cerebrovascular Diseases (Basel, Switzerland)|April 24, 2026
Functional and Patient-reported Outcomes in the Atorvastatin versus Placebo Trial of Hemorrhagic Cerebral Cavernous Malformations: An Exploratory StudyGeorgeio Sader, Roberto J Alcazar-Felix, Aditya Jhaveri, et al.
Frontiers in Physiology|January 28, 2026
Exploring the physiological limits of aging: a case study of the male 50-km world record in the 80+ age categoryA M Pilotto, E Higueras-Liébana, M Ansaldo, et al.
Journal of the American Heart Association|January 29, 2026
Recurrent Symptomatic Hemorrhage in Cerebral Cavernous Malformations After Discontinuation of Atorvastatin or PlaceboBader Ali, Robert Shenkar, Justine Lee, et al.
Acta Neuropathologica Communications|September 24, 2025
A mouse model of stereotactic radiosurgery-induced neuroinflammation and blood-brain barrier compromiseRoberto J Alcazar-Felix, Lin Cheng, Abhinav Srinath, et al.
Neurosurgery|October 21, 2025
Relevance of Lesion Volume as an Outcome in Cerebral Cavernous Malformation Drug Trial: Exploratory Analyses in Atorvastatin Treatment of Cavernous Angiomas with Symptomatic Hemorrhage Exploratory Proof of ConceptRoberto J Alcazar-Felix, Richard E Thompson, Agnieszka Stadnik, et al.
International Journal of Molecular Sciences|May 7, 2025
A Systematic Review of MicroRNAs in Hemorrhagic Neurovascular Disease: Cerebral Cavernous Malformations as a ParadigmRoberto J Alcazar-Felix, Aditya Jhaveri, Javed Iqbal, et al.
Translational Stroke Research|July 9, 2024
Except for Robust Outliers, Rapamycin Increases Lesion Burden in a Murine Model of Cerebral Cavernous MalformationsRoberto J Alcazar-Felix, Robert Shenkar, Christian R Benavides, et al.
Pageof 3